Vstm3 is a member of the CD28 family and an important modulator of T-cell function-Reference-Cited by-同舟云学术

Vstm3 is a member of the CD28 family and an important modulator of T-cell function

Published:2011-03-18 Issue:4 Volume:41 Page:902-915
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Levin Steven D.,Taft David W.,Brandt Cameron S.,Bucher Christoph,Howard Edward D.,Chadwick Eric M.,Johnston Janet,Hammond Angela,Bontadelli Kristen,Ardourel Daniel,Hebb LuAnn,Wolf Anitra,Bukowski Thomas R.,Rixon Mark W.,Kuijper Joseph L.,Ostrander Craig D.,West James W.,Bilsborough Janine,Fox Brian,Gao Zeren,Xu Wenfeng,Ramsdell Fred,Blazar Bruce R.,Lewis Katherine E.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.201041136/fullpdf

Reference47 articles.

1. The B7 family revisited;Greenwald;Annu. Rev. Immunol.,2005

2. The B7/CD28 costimulatory family in autoimmunity;Keir;Immunol. Rev.,2005

3. The B7-CD28 superfamily;Sharpe;Nat. Rev. Immunol.,2002

4. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator;Sedy;Nat. Immunol.,2005

5. Signalling to suit function: tailoring phosphoinositide 3-kinase during T-cell activation;Parry;Trends Immunol.,2007

Cited by 279 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TIGIT: Will it be the next star therapeutic target like PD-1 in hematological malignancies?;Critical Reviews in Oncology/Hematology;2024-09

2. Surface Immune Checkpoints as Potential Biomarkers in Physiological Pregnancy and Recurrent Pregnancy Loss;International Journal of Molecular Sciences;2024-08-29

3. Target therapy of TIGIT; a novel approach of immunotherapy for the treatment of colorectal cancer;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-19

4. The Nectin family ligands, PVRL2 and PVR, in cancer immunology and immunotherapy;Frontiers in Immunology;2024-08-02

5. TIGIT expression on neoplastic cells is a poor prognostic factor for adult T-cell leukaemia/lymphoma;Pathology;2024-08